Response to comment on: Toward an optimal contraception dosing strategy
2024

Response to Comments on Contraceptive Dosing Strategy

Commentary Evidence: moderate

Author Information

Author(s): Gavina Brenda Lyn A., de los Reyes V Aurelio A., Olufsen Mette S., Lenhart Suzanne, Ottesen Johnny T.

Primary Institution: Institute of Mathematics, University of the Philippines Diliman

Conclusion

The study suggests that optimizing the timing and dosage of estrogen and progestin can reduce overall hormone exposure while maintaining efficacy and safety.

Supporting Evidence

  • The study emphasizes the importance of modeling to simulate different dosing strategies.
  • It highlights the variability in menstrual cycles and the need for personalized dosing.
  • The authors agree that estrogen-only contraceptives pose significant risks.
  • The study suggests that optimal dosing can reduce hormone exposure while maintaining effectiveness.

Takeaway

This study looks at how to give contraceptives in a way that uses less medicine while still being effective, by timing the doses better.

Potential Biases

The study acknowledges potential risks associated with estrogen-only contraceptives.

Limitations

The study does not account for pharmacokinetics and is limited to certain types of contraceptives.

Digital Object Identifier (DOI)

10.1371/journal.pcbi.1012649

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication